Topic

Director of Digital Engagement & Optimization, ClinOne 

Articles

Increased outreach is necessary to combat poor recruitment and large focus on patients near study centers.


Build Relationships with HCPs to Reach Potential Clinical Trial Patients

CEO, Sickle Cell Reproductive Health Education Directive

Decentralized trials provide promise for lowering barriers in participation, but industry must continue to be proactive in patient centricity.

Making Clinical Research More Equitable Makes for More Effective Medications

Andrea Zobel, PhD, Senior Director of Personalized Supply Chain at AmerisourceBergen’s World Courier, and Graham Wylie, MBBS, Executive Chairman & Founder of the Medical Research Network (MRN), discuss the demand for DCTs, challenges surrounding them, and what their future holds.

Where Does Direct-to-Patient Fit in a Post-COVID World? 

COVID spotlights the troubling disparity in clinical research representation. How can we remove these barriers?

Clinical Research Needs Greater Participant Diversity

Experts discuss solving the EHR-compatibility puzzle in point-of-care trials.

‘Record’ Gains in Bringing Research Closer to the Patient

Kevin Aniskovich, president and CEO of Jumo Health, discusses its foray into the clinical trials arena, which includes delivering multimedia educational resources to more than 200 trials spanning 90-plus languages in more than 75 countries. 

Filling the Gaps in Clinical Trial Education, Literacy 

Trial Execution Consulting Associate, KCR Consulting

By decentralizing trials whenever feasible, sites can decrease patient burden, clinops workload, and the number of on-site participants.  

Patient-Centered Recruitment and Retention

In this interview, Patrice Matchaba, MD, President of Novartis US Foundation discusses how the biopharmaceutical industry can regain the trust of minorities.

Engaging Minorities is All About Trust in Clinical Trials

Center for Information and Study on Clinical Research Participation (CISCRP), Boston, MA, USA

Associate Director, Medical Writing, CISCRP

Examining the Current Value of ClinicalTrials.gov Listings for Patients and the Public

In light of Facebook ban on ads targeting patients, industry has chance to reinvent digital advertising for trials.

Patient Participation